Only 35% of physicians are aware of the FDA’s class-wide safety plan for certain opioids, a survey showed, suggesting an awareness challenge as the plan gets under way.
What’s more important to pharma execs? A large paycheck or a great place to work?
August 26, 2012
4:00 pm
MM&M’s 26th annual Career & Salary Survey is now open. Help us to give you the truest picture of salaries, opportunities, migration, aspirations and opinions within pharma and healthcare marketing.
At work, Sermo docs prefer the Epocrates app, MM&M poll finds
Doctors responding to an MM&M survey hosted by Sermo – a social network for practicing physicians – said they use the Epocrates mobile app more often for work purposes than any other app.
Primary care physicians gave GlaxoSmithKline sales reps the highest marks on a quality scale, according to an SDI study. The higher physician ratings corresponded with a 12% decline in the number of sales calls GSK reps made to PCPs.
Few patients look to pharma sites for health info, survey says
Patients taking a medication and looking online for health information tend to avoid pharmaceutical company sites, according to an online survey conducted by Accenture.
About.com users find drug ads more helpful in 2010, survey says
Online drug ads are significantly more helpful this year, particularly with respect to side effect and safety information, according to an About.com survey of its users.
Physicians going online (via computer) for health information visit professional sites most often, and they visit WebMD’s Medscape — a free portal for physicians — more than any other, according to a comScore/ImpactRx study.
Patients look to docs for web suggestions — but most don’t get them
Consumers want more help from their doctors in finding relevant health information on the web, but their doctors are often failing to deliver, according to new research by consumer engagement specialist Kyp and Opinion Research Corporation.
Consumers want unbranded sites, despite FDA warnings
Despite recent FDA missives regarding pharma-sponsored educational sites, consumers want condition awareness information from drugmakers, including a link to the brand, a Manhattan Research study found.